| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 2,777 | 1,999 | ||
| Prepaid expenses and other assets | 3,090 | 2,285 | ||
| Assets held for sale | 3 | 11 | ||
| Total current assets | 5,870 | 4,295 | ||
| Property and equipment, net | 0 | 0 | ||
| Right of use assets - operating leases | 684 | 717 | ||
| Deferred financing costs | 0 | 0 | ||
| Total assets | 6,554 | 5,012 | ||
| Accounts payable | 5,571 | 4,757 | ||
| Accrued expenses | 1,088 | 2,528 | ||
| Deferred revenue | 0 | 0 | ||
| Operating lease liabilities | 153 | 703 | ||
| Finance lease liabilities | 0 | 349 | ||
| Other current liabilities | 0 | 613 | ||
| Total current liabilities | 6,812 | 8,950 | ||
| Deferred revenue | 0 | 41,250 | ||
| Operating lease liabilities | 609 | 648 | ||
| Finance lease liabilities | 0 | 0 | ||
| Other long-term liabilities | 0 | 169 | ||
| Total liabilities | 7,421 | 51,017 | ||
| Common stock 0.001 par value, 350,000,000 shares authorized, 41,788,096 and 41,750,109 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 41 | 41 | ||
| Additional paid-in capital | 278,994 | 278,573 | ||
| Accumulated deficit | -279,902 | -324,619 | ||
| Total stockholders' deficit | -867 | -46,005 | ||
| Total liabilities and stockholders' deficit | 6,554 | 5,012 | ||
Carisma Therapeutics Inc. (CARM)
Carisma Therapeutics Inc. (CARM)